These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 11212815

  • 21. Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders.
    Molica S, Santoro R, Iuliano F, Di Raimondo F, Fichera E, Giustolisi R.
    Haematologica; 2001 Jul; 86(7):771. PubMed ID: 11454538
    [No Abstract] [Full Text] [Related]

  • 22. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S.
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [Abstract] [Full Text] [Related]

  • 23. [POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
    Sintaro H, Hiroshi O, Shuji O, Masashi U, Atsuo T, Chihiro T, Masako H, Naoyuki K.
    Nihon Naika Gakkai Zasshi; 2002 Feb 10; 91(2):752-4. PubMed ID: 11917504
    [No Abstract] [Full Text] [Related]

  • 24. [A case of polyneuropathy associated with increased levels of vascular endotherial growth factor (VEGF) insera].
    Shibuya S, Aihara N, Tsukamoto T, Itoyama Y.
    Rinsho Shinkeigaku; 2001 Oct 10; 41(10):665-7. PubMed ID: 11993185
    [Abstract] [Full Text] [Related]

  • 25. Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor.
    Soubrier M, Guillon R, Dubost JJ, Serre AF, Ristori JM, Boyer L, Sauvezie B.
    J Rheumatol; 1998 Apr 10; 25(4):813-5. PubMed ID: 9558193
    [Abstract] [Full Text] [Related]

  • 26. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS.
    Stem Cells; 2003 Apr 10; 21(1):118-9. PubMed ID: 12529559
    [No Abstract] [Full Text] [Related]

  • 27. Angiogenesis in hematologic malignancies.
    Mesters RM.
    Ann Hematol; 2002 Apr 10; 81 Suppl 2():S72-4. PubMed ID: 12611085
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor.
    Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, Piette JC, Chapman A, Authier FJ, Gherardi RK.
    Arthritis Rheum; 1997 Apr 10; 40(4):786-7. PubMed ID: 9125266
    [No Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor: promise or peril?
    Kipshidze N.
    Am J Cardiol; 1999 Jun 01; 83(11):1592. PubMed ID: 10363882
    [No Abstract] [Full Text] [Related]

  • 31. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
    Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D.
    Nat Med; 2001 May 01; 7(5):569-74. PubMed ID: 11329058
    [Abstract] [Full Text] [Related]

  • 32. [Crow-Fukase syndrome and VEGF].
    Arimura K, Hashiguchi T, Watanabe O.
    Brain Nerve; 2008 Jun 01; 60(6):611-9. PubMed ID: 18567356
    [Abstract] [Full Text] [Related]

  • 33. Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?
    Ungvari Z, Pacher P, Csiszar A.
    Med Hypotheses; 2002 Jan 01; 58(1):85-6. PubMed ID: 11863404
    [Abstract] [Full Text] [Related]

  • 34. Too many vessels? Not enough? The wrong kind? The VEGF debate continues.
    Ware JA.
    Nat Med; 2001 Apr 01; 7(4):403-4. PubMed ID: 11283656
    [No Abstract] [Full Text] [Related]

  • 35. [Vascular endothelial growth factor and nitric oxide].
    Liu YQ, Zhou AR.
    Sheng Li Ke Xue Jin Zhan; 2000 Jan 01; 31(1):69-71. PubMed ID: 12532773
    [No Abstract] [Full Text] [Related]

  • 36. [Vascular growth and non-small cell lung cancer].
    Fan X, Guo X, Han B.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug 01; 24(8):499-502. PubMed ID: 11718044
    [No Abstract] [Full Text] [Related]

  • 37. [The biology of lymphatic vessels - new findings ].
    Jussila L, Alitalo K, Kaipainen A.
    Duodecim; 1998 Aug 01; 114(4):343-8. PubMed ID: 11466946
    [No Abstract] [Full Text] [Related]

  • 38. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G, Heidenreich R, Gaumann A, Groot M, Licht A, Nicolaus A, Schmitz J, Reichmann E, Plate KH, Vajkoczy P.
    Ann Hematol; 2002 Aug 01; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract] [Full Text] [Related]

  • 39. Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty.
    Roller RE, Renner W, Tischler R, Pilger E, Schnedl WJ.
    Thromb Haemost; 2001 Jun 01; 85(6):1119-20. PubMed ID: 11434696
    [No Abstract] [Full Text] [Related]

  • 40. Ascites revisited: a novel role for tamoxifen.
    Donovan D, Harmey JH, Redmond HP, Bouchier-Hayes D.
    Eur J Surg Oncol; 1997 Dec 01; 23(6):570. PubMed ID: 9484934
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.